Nitric oxide synthase gene therapy enhances the toxicity of cisplatin in cancer cells

Catherine Adams, Helen O. McCarthy, Jonathan A. Coulter, Jenny Worthington, Claire Murphy, Tracy Robson, Davi G. Hirst

    Research output: Contribution to journalArticlepeer-review

    46 Citations (Scopus)


    Background Nitric oxide (NO center dot) derived from donor drugs has been shown to be an effective chemosensitizer in vitro. We investigated the combination of inducible nitric oxide synthase (iNOS) gene transfer, driven by a strong constitutive promoter (cytomegalovirus; CMV) with the DNA cross-linking agent cisplatin in mouse and human tumour cell lines. Methods Proof of principal experiments were performed in the radiation-induced fibrosarcoma-1 (RIF-1) murine cell line. Cells were transfected with constitutively expressed CMV/iNOS plasmid DNA using a cationic lipid vector, before exposure to cisplatin. In vivo efficacy was determined in an intradermal RIF-1 turnout model, with intraperitoneal administration of cisplatin. Additionally, treatment potential was investigated in various human turnout cell lines including human prostate (DU145 and PC3) and human colon (HT29 and HCT116) cancer cell lines. Experimental endpoints were established using western blot, Greiss test, clonogenic assay and turnout growth delay. Results Transfection of RIF-1 turnout cells in vitro with the CMV/iNOS significantly enhanced the cytotoxicity of cisplatin (0.2-1.0 PM). In vivo transfer of CMV/iNOS by direct injection into established RIF-1 tumours caused a significant (p = 0.0027) delay in turnout growth. CMV/iNOS gene transfer in vitro resulted in the strong expression of iNOS DNA in all cell lines, and significantly increased levels of NO center dot in all cell lines except HCT116. Conclusions Significant chemosensitization of cisplatin cytotoxicity was observed in the presence of NO center dot derived from the overexpression iNOS. We conclude that p53 status of the various cell lines was unlikely to be responsible for cisplatin-induced apoptosis. Copyright (C) 2008 John Wiley & Sons, Ltd.
    Original languageEnglish
    Pages (from-to)160-168
    JournalJournal of Gene Medicine
    Issue number2
    Publication statusPublished (in print/issue) - Feb 2009


    Dive into the research topics of 'Nitric oxide synthase gene therapy enhances the toxicity of cisplatin in cancer cells'. Together they form a unique fingerprint.

    Cite this